FDA-cleared system in 38 hospitals targets wrong-lung feeding tube risk.
NView Medical is a compelling early-stage play because its FDA-cleared system is already deployed in 38 hospitals and targets preventable feeding-tube misplacements.
The bull case emphasizes real clinical deployment and regulatory clearance, with an FDA-cleared electromagnetic navigation system already in 38 hospitals. It also links growth to expansion into pediatric and vascular access, while acknowledging execution risk, small micro-cap liquidity risk, and potential dilution needs.
"This Is An (EARLY) Once-In-A-Lifetime Opportunity"